"Abstract Importance: The epithelial-mesenchymal transition (EMT) is a well-established process leading to metastasis, which is responsible for the majority of cancer-related deaths. EMT represents a critical step in the development of tumors, and is distinguishable through specific characteristics in tumor cells, such as the ability to invade and resist pharmacological treatments. Growth differentiation factor 15 (GDF-15) is a distinct member of the transforming growth factor β (TGF- β) superfamily which increases metastasis of cells both in vitro and in vivo by inducing EMT. Observations: High GDF-15 levels in certain cancers, including endometrial, prostate, pan-creatic, and colorectal cancer (CRC), may be associated with poor clinical outcomes. Higher plasma concentrations of GDF-15 have been linked to an increased risk of developing CRC and colorectal CRC-related mortality prior to a diagnosis of CRC. It has been observed that surgical excision of CRC reduces serum GDF-15, which increases when the tumor progresses, and that monitoring serum levels after surgery may aid in the prediction of cancer recurrence. However, data showed that GDF-15 regulation promoted 5-Fluorouracil
📖 افتح في inklap 🔗 DOI 📮 اطلب بحثاً